Skip to main content
. 2016 Jun 13;71(10):940–949. doi: 10.1136/thoraxjnl-2015-208262

Figure 3.

Figure 3

Data network. Data networks (A) for the main analysis containing all isoniazid resistance patterns, (B) for the main analysis excluding the inconsistent study. Thickness of lines and numbers indicate the number of studies making this comparison. *One study arm classifiable as RIF ED≥3 Pr6 D=6m, RIF ED<3 Pr6 D=6m or RIF ED<3 D=6m compared with RIF ED<3 D=6m; here listed as RIF ED≥3 Pr6 D=6m as per main analysis. ED, effective drugs; RIF, rifampicin.